For an 80‑year‑old female with a prior cerebrovascular accident (CVA), hypertension (HTN), hyperlipidemia (HLD), peripheral vascular disease (PVD), and mild orthostatic dizziness who is taking aspirin 325 mg daily plus as‑needed aspirin 81 mg, is this aspirin dosing appropriate and what medication adjustments are recommended?

Aspirin Dosing Recommendation for This Patient

This patient's aspirin regimen is inappropriate and potentially dangerous—she should be taking aspirin 81 mg once daily only, with immediate discontinuation of the 325 mg dose and the as-needed 81 mg dose. 1

Critical Issues with Current Regimen

The patient is currently prescribed:

• Aspirin 325 mg daily
• Aspirin 81 mg as needed
• This creates potential for excessive aspirin exposure and significantly increased bleeding risk 2

For adults aged 80 and older with prior CVA (secondary prevention), aspirin should be used with caution, and lower doses are strongly preferred. 1

Evidence-Based Dosing for This Patient

Secondary Prevention After Stroke

Aspirin 81 mg daily is the appropriate dose for secondary stroke prevention in this 80-year-old woman. 1

• After PCI or in established cardiovascular disease, 81 mg daily is reasonable and preferred over higher maintenance doses 1
• The ADAPTABLE trial demonstrated no significant differences in cardiovascular events or major bleeding between 81 mg and 325 mg daily in patients with established cardiovascular disease 3
• There is no evidence that doses higher than 75-81 mg daily are more effective for secondary prevention 1

Age-Specific Considerations

In patients aged 80 and older, the bleeding risk with aspirin substantially increases, making lower doses imperative. 1

• The FDA label specifically warns that stomach bleeding risk is higher in patients age 60 or older 2
• American Geriatrics Society guidelines explicitly state that for adults aged 80 and older, aspirin should be used with caution 1
• No evidence supports higher doses being more effective than 75 mg daily, even in older adults 1

Bleeding Risk Assessment

This patient has multiple bleeding risk factors:

• Age 80 years (significantly elevated risk) 2
• Currently on high-dose aspirin 325 mg 2
• Potential for duplicate dosing with as-needed 81 mg 2
• Concurrent acetaminophen use (though less concerning) 2

The chance of stomach bleeding requiring hospitalization increases with age, and this patient's current regimen substantially amplifies this risk. 2

Specific Medication Adjustments

Immediate Changes Required

1. Discontinue aspirin 325 mg daily immediately 1
2. Discontinue aspirin 81 mg as needed immediately 1
3. Prescribe aspirin 81 mg once daily for secondary stroke prevention 1

Rationale for Single Low-Dose Aspirin

• The 2021 AHA/ASA Stroke Prevention Guidelines support single antiplatelet therapy for secondary prevention in noncardioembolic stroke 1
• The 2014 AHA/ACC guidelines recommend 81 mg daily as reasonable after PCI and for established cardiovascular disease 1
• Recent evidence from ADAPTABLE shows equivalent efficacy between 81 mg and 325 mg with no age-dose interaction 4, 3

Additional Cardiovascular Medication Review

Blood Pressure Management

Her current losartan 50 mg daily is appropriate, but blood pressure should be monitored for orthostatic changes given her dizziness. 1

• Target BP <140/90 mmHg is appropriate for her age 1
• Orthostatic hypotension should be assessed given her reported dizziness with position changes 1
• BP should be measured in both sitting and standing positions 1

Lipid Management

Atorvastatin 40 mg daily is appropriate for secondary prevention after CVA. 1

Common Pitfalls to Avoid

1. Never prescribe both scheduled and as-needed aspirin concurrently—this creates dangerous potential for overdosing 2
2. Do not assume higher aspirin doses provide better protection—evidence shows no benefit above 75-81 mg daily for secondary prevention 1, 3
3. Do not overlook age-related bleeding risk—patients ≥80 years require special caution with aspirin 1, 2
4. Do not continue high-dose aspirin simply because it was previously prescribed—dose optimization is essential, especially in elderly patients 1, 3

Monitoring Recommendations

After switching to aspirin 81 mg daily, monitor for: 2

• Signs of bleeding (melena, hematochezia, unusual bruising)
• Orthostatic vital signs at follow-up visits 1
• Medication adherence and absence of duplicate aspirin sources
• Any gastrointestinal symptoms suggesting bleeding 2